A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
-
Published:2016-11-24
Issue:3
Volume:76
Page:554-561
-
ISSN:0003-4967
-
Container-title:Annals of the Rheumatic Diseases
-
language:en
-
Short-container-title:Ann Rheum Dis
Author:
van Vollenhoven Ronald, Voskuyl Alexandre, Bertsias George, Aranow Cynthia, Aringer Martin, Arnaud Laurent, Askanase Anca, Balážová Petra, Bonfa Eloisa, Bootsma Hendrika, Boumpas Dimitrios, Bruce Ian, Cervera Ricard, Clarke Ann, Coney Cindy, Costedoat-Chalumeau Nathalie, Czirják László, Derksen Ronald, Doria Andrea, Dörner Thomas, Fischer-Betz Rebecca, Fritsch-Stork Ruth, Gordon Caroline, Graninger Winfried, Györi Noémi, Houssiau Frédéric, Isenberg David, Jacobsen Soren, Jayne David, Kuhn Annegret, Le Guern Veronique, Lerstrøm Kirsten, Levy Roger, Machado-Ribeiro Francinne, Mariette Xavier, Missaykeh Jamil, Morand Eric, Mosca Marta, Inanc Murat, Navarra Sandra, Neumann Irmgard, Olesinska Marzena, Petri Michelle, Rahman Anisur, Rekvig Ole Petter, Rovensky Jozef, Shoenfeld Yehuda, Smolen JosefORCID, Tincani Angela, Urowitz Murray, van Leeuw Bernadette, Vasconcelos Carlos, Voss Anne, Werth Victoria P, Zakharova Helena, Zoma Asad, Schneider Matthias, Ward Michael
Abstract
ObjectivesTreat-to-target recommendations have identified ‘remission’ as a target in systemic lupus erythematosus (SLE), but recognise that there is no universally accepted definition for this. Therefore, we initiated a process to achieve consensus on potential definitions for remission in SLE.MethodsAn international task force of 60 specialists and patient representatives participated in preparatory exercises, a face-to-face meeting and follow-up electronic voting. The level for agreement was set at 90%.ResultsThe task force agreed on eight key statements regarding remission in SLE and three principles to guide the further development of remission definitions:1. Definitions of remission will be worded as follows: remission in SLE is a durable state characterised by …………………. (reference to symptoms, signs, routine labs).2. For defining remission, a validated index must be used, for example, clinical systemic lupus erythematosus disease activity index (SLEDAI)=0, British Isles lupus assessment group (BILAG) 2004 D/E only, clinical European consensus lupus outcome measure (ECLAM)=0; with routine laboratory assessments included, and supplemented with physician's global assessment.3. Distinction is made between remission off and on therapy: remission off therapy requires the patient to be on no other treatment for SLE than maintenance antimalarials; and remission on therapy allows patients to be on stable maintenance antimalarials, low-dose corticosteroids (prednisone ≤5 mg/day), maintenance immunosuppressives and/or maintenance biologics.The task force also agreed that the most appropriate outcomes (dependent variables) for testing the prognostic value (construct validity) of potential remission definitions are: death, damage, flares and measures of health-related quality of life.ConclusionsThe work of this international task force provides a framework for testing different definitions of remission against long-term outcomes.
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology
Cited by
283 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|